A combination of Botulinum Toxin A therapy and functional electrical stimulation in children with cerebral palsy - A pilot study.

Sujay Galen, Laura Wiggins, Robert McWilliam, Malcolm Granat

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Among the ambulant population of children with spastic cerebral palsy (CP), dynamic equinus is one of the most common form of gait deviation that is encountered. To investigate the combined effects of Functional Electrical Stimulation (FES) and Botulinum Toxin A (BTXA) therapy in children with spastic CP, and to demonstrate the feasibility of this combination therapy. A single-subject design with repeated measures was adopted. Eight children (six males, two females; mean age 7 y 9 mo, SD 1 y 5 mo; range 7 y to 11 y) diagnosed with hemiplegic (n=6) or diplegic (n=2) spastic CP completed the study. Each subject participated in the study for twenty weeks. This period consisted of baseline (one week), BTXA phase (three weeks), first FES phase (four weeks), first control phase (four weeks), second FES phase (four weeks) and second control phase (four weeks). Subjects were assessed at the end of each phase. The ankle angle at the end of swing phase was selected as the primary outcome measure. The secondary outcome measure recorded was the foot contact pattern. There was an increase in ankle dorsiflexion at the end of the combined intervention in most subjects (n=6), accompanied by an improvement in foot contact pattern. This pilot study demonstrated that it is feasible to combine BTXA therapy with FES in ambulant children with spastic CP.
    LanguageEnglish
    Pages1-9
    Number of pages9
    JournalTechnology and Health Care
    Volume20
    Issue number1
    Publication statusPublished - 2012

    Fingerprint

    Electric Stimulation Therapy
    Type A Botulinum Toxins
    Phase control
    Cerebral Palsy
    Electric Stimulation
    Ankle
    Foot
    Outcome Assessment (Health Care)
    Gait
    Therapeutics
    Population

    Keywords

    • combination
    • botulinum
    • toxin a therapy
    • functional electrical stimulation
    • children
    • cerebral palsy
    • pilot study

    Cite this

    Galen, Sujay ; Wiggins, Laura ; McWilliam, Robert ; Granat, Malcolm. / A combination of Botulinum Toxin A therapy and functional electrical stimulation in children with cerebral palsy - A pilot study. In: Technology and Health Care. 2012 ; Vol. 20, No. 1. pp. 1-9.
    @article{3cf7284049a440ddb461e7b91edce006,
    title = "A combination of Botulinum Toxin A therapy and functional electrical stimulation in children with cerebral palsy - A pilot study.",
    abstract = "Among the ambulant population of children with spastic cerebral palsy (CP), dynamic equinus is one of the most common form of gait deviation that is encountered. To investigate the combined effects of Functional Electrical Stimulation (FES) and Botulinum Toxin A (BTXA) therapy in children with spastic CP, and to demonstrate the feasibility of this combination therapy. A single-subject design with repeated measures was adopted. Eight children (six males, two females; mean age 7 y 9 mo, SD 1 y 5 mo; range 7 y to 11 y) diagnosed with hemiplegic (n=6) or diplegic (n=2) spastic CP completed the study. Each subject participated in the study for twenty weeks. This period consisted of baseline (one week), BTXA phase (three weeks), first FES phase (four weeks), first control phase (four weeks), second FES phase (four weeks) and second control phase (four weeks). Subjects were assessed at the end of each phase. The ankle angle at the end of swing phase was selected as the primary outcome measure. The secondary outcome measure recorded was the foot contact pattern. There was an increase in ankle dorsiflexion at the end of the combined intervention in most subjects (n=6), accompanied by an improvement in foot contact pattern. This pilot study demonstrated that it is feasible to combine BTXA therapy with FES in ambulant children with spastic CP.",
    keywords = "combination, botulinum, toxin a therapy, functional electrical stimulation, children, cerebral palsy, pilot study",
    author = "Sujay Galen and Laura Wiggins and Robert McWilliam and Malcolm Granat",
    year = "2012",
    language = "English",
    volume = "20",
    pages = "1--9",
    journal = "Technology and Health Care",
    issn = "0928-7329",
    number = "1",

    }

    A combination of Botulinum Toxin A therapy and functional electrical stimulation in children with cerebral palsy - A pilot study. / Galen, Sujay; Wiggins, Laura; McWilliam, Robert; Granat, Malcolm.

    In: Technology and Health Care, Vol. 20, No. 1, 2012, p. 1-9.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - A combination of Botulinum Toxin A therapy and functional electrical stimulation in children with cerebral palsy - A pilot study.

    AU - Galen, Sujay

    AU - Wiggins, Laura

    AU - McWilliam, Robert

    AU - Granat, Malcolm

    PY - 2012

    Y1 - 2012

    N2 - Among the ambulant population of children with spastic cerebral palsy (CP), dynamic equinus is one of the most common form of gait deviation that is encountered. To investigate the combined effects of Functional Electrical Stimulation (FES) and Botulinum Toxin A (BTXA) therapy in children with spastic CP, and to demonstrate the feasibility of this combination therapy. A single-subject design with repeated measures was adopted. Eight children (six males, two females; mean age 7 y 9 mo, SD 1 y 5 mo; range 7 y to 11 y) diagnosed with hemiplegic (n=6) or diplegic (n=2) spastic CP completed the study. Each subject participated in the study for twenty weeks. This period consisted of baseline (one week), BTXA phase (three weeks), first FES phase (four weeks), first control phase (four weeks), second FES phase (four weeks) and second control phase (four weeks). Subjects were assessed at the end of each phase. The ankle angle at the end of swing phase was selected as the primary outcome measure. The secondary outcome measure recorded was the foot contact pattern. There was an increase in ankle dorsiflexion at the end of the combined intervention in most subjects (n=6), accompanied by an improvement in foot contact pattern. This pilot study demonstrated that it is feasible to combine BTXA therapy with FES in ambulant children with spastic CP.

    AB - Among the ambulant population of children with spastic cerebral palsy (CP), dynamic equinus is one of the most common form of gait deviation that is encountered. To investigate the combined effects of Functional Electrical Stimulation (FES) and Botulinum Toxin A (BTXA) therapy in children with spastic CP, and to demonstrate the feasibility of this combination therapy. A single-subject design with repeated measures was adopted. Eight children (six males, two females; mean age 7 y 9 mo, SD 1 y 5 mo; range 7 y to 11 y) diagnosed with hemiplegic (n=6) or diplegic (n=2) spastic CP completed the study. Each subject participated in the study for twenty weeks. This period consisted of baseline (one week), BTXA phase (three weeks), first FES phase (four weeks), first control phase (four weeks), second FES phase (four weeks) and second control phase (four weeks). Subjects were assessed at the end of each phase. The ankle angle at the end of swing phase was selected as the primary outcome measure. The secondary outcome measure recorded was the foot contact pattern. There was an increase in ankle dorsiflexion at the end of the combined intervention in most subjects (n=6), accompanied by an improvement in foot contact pattern. This pilot study demonstrated that it is feasible to combine BTXA therapy with FES in ambulant children with spastic CP.

    KW - combination

    KW - botulinum

    KW - toxin a therapy

    KW - functional electrical stimulation

    KW - children

    KW - cerebral palsy

    KW - pilot study

    M3 - Article

    VL - 20

    SP - 1

    EP - 9

    JO - Technology and Health Care

    T2 - Technology and Health Care

    JF - Technology and Health Care

    SN - 0928-7329

    IS - 1

    ER -